Venture investors are adopting a more aggressive mindset heading into 2026, while Merck, Moderna and Summit are all ...

Startups raised $14.2 billion last year, the highest funding total since 2022. Health AI companies collected 54% of total ...

Regulatory and clinical roadblocks have set back its oral BTK inhibitor tolebrutinib, but the drug class still has many ...

As with the many other “most-favored-nation” deals between the White House and large pharmas, the agreement is short on ...